Krsnaa Diagnostics Ltd
Diversified Consumer Services | Small Cap
Krsnaa Diagnostics Ltd demonstrates a mixed financial performance. The company shows strong solvency and growth, reflected in its high equity ratio and robust growth rates in revenue and operating profit. Profitability metrics such as gross profit margin and return on assets (ROA) are also noteworthy. However, liquidity ratios are poor, indicating potential challenges in meeting short-term obligations. Efficiency ratios are also low, suggesting the company could improve its asset utilization. Furthermore, some financial metrics like adjusted EPS and net margin are concerning, highlighting areas needing attention to ensure sustainable financial health. Overall, Krsnaa Diagnostics exhibits strengths in long-term financial stability and growth, but needs to address its liquidity and efficiency to enhance its competitive positioning in the healthcare services sector. Future performance will depend on addressing these weaknesses and capitalizing on growth opportunities.
Latest Report
View AllThe Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.
Latest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsNeutral
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio8.00
- Financial Ratio5.20
- Profitability Ratio7.20
- Efficiency Ratio4.67
- Coverage Ratio6.80
- Solvency Ratio10.00
- Liquidity Ratio2.00
- Peer Assessment
- Management AssessmentBalanced
- Risk AssessmentBalanced
- 1 HourBearish
- 2 HoursBearish
- 4 HoursBearish
- 1 DayNeutral
- 1 WeekBearish
- 1 MonthBearish
Krsnaa Diagnostics Ltd demonstrates a mixed financial performance. The company shows strong solvency and growth, reflected in its high equity ratio and robust growth rates in revenue and operating profit. Profitability metrics such as gross profit margin and return on assets (ROA) are also noteworthy. However, liquidity ratios are poor, indicating potential challenges in meeting short-term obligations. Efficiency ratios are also low, suggesting the company could improve its asset utilization. Furthermore, some financial metrics like adjusted EPS and net margin are concerning, highlighting areas needing attention to ensure sustainable financial health. Overall, Krsnaa Diagnostics exhibits strengths in long-term financial stability and growth, but needs to address its liquidity and efficiency to enhance its competitive positioning in the healthcare services sector. Future performance will depend on addressing these weaknesses and capitalizing on growth opportunities.
Overall Valuation Score
P/E RATIO (TTM)
16.79
Industry Median
31.45
Small Cap Median
31.45
P/E RATIO
16.99
P/B RATIO
1.76
Industry Median
3.67
Small Cap Median
3.67
P/S RATIO
2.27
Industry Median
3.31
Small Cap Median
3.31
Others
PEG RATIO
0.00
EV/EBITDA RATIO
7.38
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹531.3 as on Jun 19, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
The company exhibits strong growth, particularly in revenue and operating profit. This indicates effective business strategies and market positioning. However, the net income growth rate is low, which could be due to various factors such as increased expenses or changes in tax policies. Maintaining a balance between revenue growth and net income growth is crucial for sustainable financial health.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 7.03 | 27.31 | 15.65 | 7.81 | |
| Operating Profit Growth Rate | -7.58 | 18.03 | 31.94 | 11.58 | |
| Earnings Per Share (EPS) Growth | -9.18 | -11.02 | 36.59 | 30.07 | |
| Asset Growth Rate | 3.77 | 28.85 | 9.23 | 42.72 | |
| Net Income Growth Rate | -8.82 | -8.06 | 36.84 | 29.49 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
The company's financial ratios present a mixed picture. The cash earnings per share and book value per share are average. The company's adjusted EPS and Capital expenditure are not good. Balancing profitability with strategic investments is important for sustainable financial health.
| Financial Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | 21.25 | 19.38 | 17.81 | 23.44 | 31.56 |
| Cash Earnings Per Share (Cash EPS) | 34.06 | 36.25 | 41.25 | 51.88 | 59.69 |
| Book Value Per Share | 214.06 | 230.94 | 253.12 | 275.94 | 306.25 |
| Dividend Per Share (DPS) | 2.4 | 2.77 | 2.46 | 2.64 | 0 |
| Capital Expenditures (CapEx) | 131 | 134 | 193 | 112 | 215 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
The company's profitability ratios are generally strong. The company maintains high gross profit margins and high returns on assets and capital employed, reflecting efficient operations. However, the return on equity and net margin are low, indicating areas that need attention. Balancing profitability across all metrics is important for sustainable financial health.
| Profitability Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Profit Margin | 20 | 13.96 | 11.13 | 14.23 | 15.78 |
| Return on Capital Employed (ROCE) | 14.58 | 12 | 10 | 12 | 13 |
| Return on Equity (ROE) | 9.93 | 8.39 | 7.04 | 8.83 | 10.31 |
| Return on Assets (ROA) | 15.09 | 13.44 | 12.31 | 14.87 | 11.62 |
| Operating Margin | 29.01 | 25.05 | 23.23 | 26.5 | 27.43 |
| Net Margin | 14.95 | 12.73 | 9.19 | 10.88 | 13.07 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
The company's efficiency ratios suggest there is room for improvement in how effectively it uses its assets. While some metrics are average, others indicate potential inefficiencies in asset management. Enhancing efficiency could improve profitability and overall financial performance. This requires a closer look at asset turnover and working capital management.
| Efficiency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | 1.18 | 1.03 | 0.96 | 1.07 | 1.18 |
| Inventory Turnover Ratio | 40.56 | 24.65 | 18.03 | 18.92 | 23.25 |
| Receivables Turnover Ratio | 7.93 | 7.44 | 4.98 | 3.16 | 2.69 |
| Days Sales in Inventory Ratio | 9 | 14.81 | 20.24 | 19.29 | 15.7 |
| Receivable Days | 46 | 49.06 | 73.29 | 115.51 | 135.69 |
| Capital Turnover Ratio | 0.63 | 0.64 | 0.71 | 0.76 | 0.53 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
The company's coverage ratios are mixed, with its interest coverage ratio performing well but equity dividend coverage is low. While it adequately covers its interest expenses, its ability to cover equity dividends is limited. Effective management of both interest and dividend coverage is important for maintaining financial stability and shareholder confidence.
| Coverage Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Interest Coverage Ratio | 5.83 | 11 | 5.38 | 5.12 | 4.82 |
| Equity Dividend Coverage Ratio | 9.09 | 7.14 | 7.14 | 9.09 |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
The company's solvency position is strong, indicating a solid long-term financial stability. This suggests the company has a healthy balance sheet and isn't overly reliant on debt. A strong solvency position provides a buffer against economic downturns and allows for strategic investments. This reflects effective capital management and a stable financial structure.
| Solvency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debt Ratio | 0.05 | 0.04 | 0.07 | 0.06 | 0.33 |
| Debt to Equity Ratio | 0.05 | 0.04 | 0.08 | 0.06 | 0.49 |
| Equity Ratio | 0.95 | 0.96 | 0.93 | 0.94 | 0.67 |
| Debt To Asset Ratio | 0.04 | 0.03 | 0.05 | 0.04 | 0.26 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
The company's liquidity position is weak, indicating potential difficulties in meeting its short-term obligations. While a low liquidity position isn't ideal, Krsnaa Diagnostics might be prioritizing long-term investments over immediate cash availability. However, this could pose risks if unexpected expenses arise. Improving liquidity could involve better management of current assets and liabilities.
| Liquidity Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Current Ratio | 2.96 | 2.88 | 1.7 | 1.69 | 2.49 |
| Quick Ratio | 2.9 | 2.71 | 1.58 | 1.6 | 2.42 |
| Cash Ratio | 1.55 | 0.76 | 0.58 | 0.2 | 1 |
| Operating Cash Flow Ratio | 0.82 | 0.53 | 0.08 | 0.26 | 0.4 |
Current Ratio
Quick Ratio
Cash Ratio
Operating Cash Flow Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Medi Assist Healthcare Services Ltd | 8.33 | 30.93 | Neutral | 175.00 | 6.96 | 89.00 |
| 2 | Krsnaa Diagnostics Ltd | 6.17 | 16.99 | Neutral | 212.00 | 31.65 | 101.00 |
| 3 | Suven Life Sciences Ltd | 5.67 | -25.59 | Neutral | -284.00 | -2.08 | -276.00 |
The management of Krsnaa Diagnostics demonstrates a mixed performance. Consistent revenue growth and stable promoter holding are positive indicators. However, volatile profit growth and increasing debt levels raise concerns. The decrease in DII holding, offset by an increase in public shareholding, suggests a shift in investor sentiment. Overall, while revenue generation remains strong, careful attention to profitability and debt management is warranted.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| PROS | Consistent Revenue Growth | Consistently increasing | Quarterly sales showing positive trend |
| Stable Promoter Holding | ~27% | Indicates alignment with shareholders | |
| CONS | Volatile Profit Growth | Fluctuating | YOY Profit Growth % varies significantly |
| Increasing Debt Levels | ₹204 Cr. | Borrowings have increased substantially |
Financial Performance & Growth
Krsnaa Diagnostics shows strong revenue growth but inconsistent profit growth. Quarterly sales have consistently increased from ₹108 Cr in Mar 2022 to ₹186 Cr in Mar 2025. YOY sales growth % has been robust. However, YOY profit growth % has been more erratic, with significant fluctuations including negative growth rates. The OPM % has shown stability, generally ranging between 20% and 28%. The company's compounded sales growth over the past 3 years is 16%, while compounded profit growth is 4%.
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Sales (₹ Cr) | 455 | 487 | 620 | 717 |
| Sales Growth (%) | - | 6.95% | 27.20% | 15.74% |
| Net Profit (₹ Cr) | 68 | 62 | 57 | 78 |
Capital Efficiency & Returns
The capital efficiency of Krsnaa Diagnostics, as indicated by Return on Capital Employed (ROCE), presents a mixed picture. The ROCE has fluctuated, showing 12% in Mar 2023, declining to 10% in Mar 2024, and then recovering to 12% in Mar 2025. The cash conversion cycle has varied.
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| ROCE (%) | 12% | 10% | 12% |
| Cash Conversion Cycle (Days) | 55 | 104 | -5 |
Financial Health & Prudence
Krsnaa Diagnostics' financial health reveals some concerning trends. Borrowings have increased significantly from ₹32 Cr in Mar 2023 to ₹204 Cr in Mar 2025. Interest payments have also risen, from ₹8 Cr in Mar 2023 to ₹25 Cr in Mar 2025. The company has been consistently sharing profits through dividends, with a dividend payout ratio of around 11-14%.
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Borrowings (₹ Cr) | 32 | 160 | 204 |
| Interest (₹ Cr) | 8 | 16 | 25 |
| Dividend Payout % | 14% | 14% | 11% |
Shareholding & Ownership Structure
The shareholding pattern of Krsnaa Diagnostics indicates stability in promoter holding but a shift in institutional and public ownership. Promoter holding has remained relatively stable around 27%. DII holding has decreased from 28.64% in Mar 2022 to 14.26% in Mar 2025. Public holding has increased from 39.49% in Mar 2022 to 54.94% in Mar 2025. FII holding has remained relatively stable at around 3-4%.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Promoter Holding (%) | 27.38% | 27.79% | 27.03% | 27.24% |
| FII Holding (%) | 4.49% | 3.39% | 3.34% | 3.55% |
| DII Holding (%) | 28.64% | 18.49% | 15.37% | 14.26% |
| Public Holding (%) | 39.49% | 50.33% | 54.27% | 54.94% |
Krsnaa Diagnostics faces moderate risk due to inconsistent profitability and increasing debt levels. The rise in borrowings and interest expenses could strain financial performance. The fluctuating cash conversion cycle indicates potential inefficiencies in working capital management. Additionally, the decreasing DII holding and increasing public holding may reflect changing investor confidence.
Off-balance sheet exposure quantification
There is no specific data available on off-balance sheet exposures for Krsnaa Diagnostics in the provided dataset.
Contingent liability evaluation
There is no specific data available on contingent liabilities for Krsnaa Diagnostics in the provided dataset.
Segment performance volatility
Krsnaa Diagnostics operates in the healthcare sector, offering a range of diagnostic services. Volatility in segment performance could arise from varying demand for different diagnostic tests, competitive pressures, or changes in healthcare regulations.
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10532.92Bearish
- SMA 20534.86Bearish
- SMA 50536.20Bearish
- EMA 10533.24Bearish
- EMA 20534.37Bearish
- EMA 50536.79Bearish
- DEMA 10532.09Bullish
- DEMA 20532.54Bearish
- DEMA 50532.83Bearish
- TEMA 10532.06Bullish
- TEMA 20532.04Bullish
- TEMA 50533.52Bearish
- MACD-1.41Bearish
- ADX20.13Weak Trend
- IndicatorValueSignal
- RSI42.45Neutral
- CCI-111.57Oversold
- ROC 9-0.33Bearish
- ROC 14-0.70Bearish
- ROC 25-1.44Bearish
- Stoch K36.48Neutral
- Stoch D29.65Neutral
- IndicatorValueSignal
- BB Upper539.71Neutral
- BB Middle534.85Neutral
- BB Lower530.00Neutral
- ATR4.31High Volatility
- IndicatorValueSignal
- MFI30.31Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10533.69Bearish
- SMA 20535.99Bearish
- SMA 50539.18Bearish
- EMA 10533.77Bearish
- EMA 20535.17Bearish
- EMA 50539.82Bearish
- DEMA 10532.31Bearish
- DEMA 20532.68Bearish
- DEMA 50530.76Bullish
- TEMA 10532.04Bullish
- TEMA 20532.64Bearish
- TEMA 50532.61Bearish
- MACD-1.89Bearish
- ADX27.15Strong Trend
- IndicatorValueSignal
- RSI43.10Neutral
- CCI-117.08Oversold
- ROC 90.05Bullish
- ROC 14-1.07Bearish
- ROC 25-0.33Bearish
- Stoch K20.62Neutral
- Stoch D14.02Oversold
- IndicatorValueSignal
- BB Upper541.75Neutral
- BB Middle535.99Neutral
- BB Lower530.23Neutral
- ATR6.21Low Volatility
- IndicatorValueSignal
- MFI24.47Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10535.90Bearish
- SMA 20537.16Bearish
- SMA 50548.14Bearish
- EMA 10534.87Bearish
- EMA 20537.71Bearish
- EMA 50548.89Bearish
- DEMA 10532.50Bearish
- DEMA 20531.54Bullish
- DEMA 50531.08Bullish
- TEMA 10532.32Bearish
- TEMA 20533.22Bearish
- TEMA 50N/AN/A
- MACD-4.41Bullish
- ADX22.59Weak Trend
- IndicatorValueSignal
- RSI41.32Neutral
- CCI-113.04Oversold
- ROC 9-1.44Bearish
- ROC 14-0.70Bearish
- ROC 25-0.91Bearish
- Stoch K9.18Oversold
- Stoch D11.91Oversold
- IndicatorValueSignal
- BB Upper545.99Neutral
- BB Middle537.16Neutral
- BB Lower528.33Neutral
- ATR10.10Low Volatility
- IndicatorValueSignal
- MFI46.11Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10537.50Bearish
- SMA 20543.01Bearish
- SMA 50573.48Bearish
- SMA 100607.09Bearish
- SMA 200695.09Bearish
- EMA 10537.64Bearish
- EMA 20545.46Bearish
- EMA 50568.78Bearish
- EMA 100606.86Bearish
- EMA 200659.32Bearish
- DEMA 10531.68Bullish
- DEMA 20529.89Bullish
- DEMA 50530.65Bullish
- DEMA 100537.37Bearish
- DEMA 200586.67Bearish
- TEMA 10533.49Bullish
- TEMA 20529.31Bullish
- TEMA 50532.23Bullish
- TEMA 100520.19Bullish
- TEMA 200533.07Bullish
- MACD-11.25Bullish
- ADX19.46Weak Trend
- IndicatorValueSignal
- RSI38.22Neutral
- CCI-95.32Neutral
- ROC 14-2.88Bearish
- ROC 25-7.65Bearish
- Stoch K9.82Oversold
- Stoch D9.36Oversold
- IndicatorValueSignal
- BB Upper560.90Neutral
- BB Middle543.01Neutral
- BB Lower525.11Neutral
- ATR17.87Low Volatility
- IndicatorValueSignal
- MFI50.65Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 20601.61Bearish
- SMA 50710.82Bearish
- EMA 20605.44Bearish
- EMA 50670.10Bearish
- DEMA 20544.86Bearish
- DEMA 50608.47Bearish
- TEMA 20533.65Bullish
- TEMA 50552.00Bearish
- MACD-44.67Bearish
- ADX27.75Strong Trend
- IndicatorValueSignal
- RSI36.13Neutral
- CCI-131.18Oversold
- ROC 14-12.49Bearish
- ROC 25-25.68Bearish
- Stoch K23.83Neutral
- Stoch D26.99Neutral
- IndicatorValueSignal
- BB Upper695.38Neutral
- BB Middle601.61Neutral
- BB Lower507.83Neutral
- ATR45.16Low Volatility
- IndicatorValueSignal
- MFI28.48Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 6621.23Bearish
- SMA 12702.25Bearish
- SMA 24742.27Bearish
- EMA 6614.38Bearish
- EMA 12665.60Bearish
- EMA 24691.62Bearish
- DEMA 6552.36Bearish
- DEMA 12607.16Bearish
- DEMA 24692.23Bearish
- TEMA 6534.48Bullish
- TEMA 12555.42Bearish
- TEMA 24N/AN/A
- MACD38.41Bearish
- ADX18.16Weak Trend
- IndicatorValueSignal
- RSI42.94Neutral
- CCI-47.88Neutral
- ROC 25-4.49Bearish
- ROC 5012.43Bullish
- Stoch K34.17Neutral
- Stoch D54.69Neutral
- IndicatorValueSignal
- BB Upper990.94Neutral
- BB Middle748.23Neutral
- BB Lower505.53Neutral
- ATR121.67Low Volatility
- IndicatorValueSignal
- MFI26.98Neutral